-
ACLA Weighs in on American Privacy Rights Act (APRA)
-
ACLA Challenges FDA’s Final Rule to Regulate Laboratory Developed Testing Services as Medical Devices
Washington, D.C. – Today the American Clinical Laboratory Association (ACLA) and its member company, HealthTrackRx, filed a lawsuit against the U.S. Food and Drug Administration ... Read More -
ACLA Challenge to FDA’s Final Rule Regulating Laboratory Developed Testing Services as Medical Devices
-
ACLA Response to CMS RFI on Medicare Advantage Data
-
ACLA Statement on FDA Final Rule to Regulate Laboratory Developed Testing Services as Medical Devices
Washington, D.C. – In response to the U.S. Food & Drug Administration (FDA) releasing its Final Rule to regulate laboratory developed testing services as medical ... Read More -
Toolkit: Medical Laboratory Professionals Week
-
Toolkit: SALSA Day of Action
-
ACLA Responds to Sen. Cassidy RFI on Diagnostic Regulation
-
ACLA Comments on USCDI+ Laboratory Data Exchange
-
ACLA Launches 2024 ‘Stop Lab Cuts’ Campaign Urging Congress to Protect Access to Laboratory Services
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today launched its 2024 Stop Lab Cuts campaign, including a series of digital advertisements urging Congress to ... Read More